Sensabues AB offers a newly discovered, novel and proprietary procedure for the collection, detection and identification of non-volatile substances in exhaled breath. These can be exogenous substances, such as drugs of abuse (narcotics), therapeutic drugs (antibiotics) and performance enhancing drugs (stimulants). Also, they can be a wide range of endogenous substances associated with the study of metabolomics and the determination of biomarkers.

This exhaled breath based biomatrix platform, ExaBreath® (EB), is transforming drug detection, health monitoring and medical diagnostics for:

  • sports doping control
  • drugs of abuse testing
  • therapeutic drug monitoring
  • biomarker detection

EB is achieving this by:

  • lowering the cost of sample collection
  • reducing specimen sampling collection time and complexity
  • making specimen sampling collection more convenient and less intrusive
  • increasing the acceptability and frequency of sample collection
  • enabling new types of collection procedures